Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  1, 29 - 33 (1992)
doi:10.1038/ng0492-29

Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A

James R. Lupski1, 2, 3, 5, Carol A. Wise1, Akira Kuwano1, Liu Pentao1, Julie T. Parke3, 5, Daniel G. Glaze3, 4, 5, David H. Ledbetter1, 2, Frank Greenberg1, 3, 5 & Pragna I. Patel1, 2

  1Institute for Molecular Genetics, Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030, USA

  2Human Genome Center, Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030, USA

  3Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030, USA

  4Department of Neurology, Section of Neurophysiology, Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030, USA

  5Texas Children's Hospital, Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030, USA

Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.

REFERENCES
  1. Charcot, J.-M. & Marie, P. Rev. Med. 6, 97−138 (1886).
  2. Tooth, H.H. The Peroneal Type of Progressive Muscular Atrophy (London, 1886).
  3. Skre, H. Clin. Genet. 6, 98−118 (1974). | PubMed  | ISI | ChemPort |
  4. Lupski, J.R., Garcia, C.A., Parry, G. & Patel, P.I. in Current Neurology Vol. 11 (ed. Appel, S.) (Mosby-Yearbook, Chicago, 1991).
  5. Bird, T.D. & Kraft, G.H. Clin. Genet. 14, 43−49 (1978). | PubMed  | ISI | ChemPort |
  6. Lupski, J.R. et al. Cell 66, 219−232 (1991). | PubMed  | ISI | ChemPort |
  7. Wright, E.C., Goldgar, D.E., Fain, P.R., Barker, D.F. & Skolnick, M.H. Genomics 7, 103−109 (1990). | PubMed  | ISI | ChemPort |
  8. Raeymaekers, P. et al. Neuromuscular Disorders 1, 93−97 (1991). | Article | PubMed  | ChemPort |
  9. Magenis, R.E., Brown, M.G., Allen, L. & Reiss, J. Am. J. med. Genet. 24, 415−420 (1986). | PubMed  | ISI | ChemPort |
  10. Docherty, Z. et al. J. med. Genet. 20, 138−142 (1983). | PubMed  | ISI | ChemPort |
  11. Kozma, C., Meek, J.M., Loomis, K.J. & Galindo, H.C. Am. J. med. Genet. 41, 446−450 (1991). | PubMed  | ISI | ChemPort |
  12. Greenberg, F. et al. Am. J. hum. Genet. 49, 1207−1218 (1991). | PubMed  | ISI | ChemPort |
  13. Nakamura, Y. et al. Genomics 2, 302−309 (1988). | PubMed  | ChemPort |
  14. Kuwano, A., Ledbetter, S.A., Dobyns, W.B., Emanuel, B.S. & Ledbetter, D.H. Am. J. hum. Genet. 49, 707−714 (1991). | PubMed  | ISI | ChemPort |
  15. Burke, D.T., Carle, G.F. & Olson, M.V. Science 236, 806−812 (1987). | PubMed  | ISI | ChemPort |
  16. Guzzetta, V. et al. Genomics, in the press.
  17. Vance, J.M. et al. Exp. Neurol. 104, 186−189 (1989). | PubMed  | ISI | ChemPort |
  18. Raeymaekers, P. Am. J. hum. Genet. 45, 953−958 (1989). | PubMed  | ISI | ChemPort |
  19. Chance, P.F. et al. Am. J. hum. Genet. 47, 915−925 (1990). | PubMed  | ISI | ChemPort |
  20. McAlpine, P.J. et al. Genomics 7, 408−415 (1990). | PubMed  | ISI | ChemPort |
  21. Middleton-Price, H.R., Harding, A.E., Montiero, C., Berciano, J. & Malcolm, S. Am. J. hum. Genet. 46, 92−94 (1990). | PubMed  | ChemPort |
  22. Patel, P.I. et al. Am. J. hum. Genet. 47, 926−934 (1990). | PubMed  | ISI | ChemPort |
  23. Timmerman, V. et al. Am. J. hum. Genet. 47, 680−685 (1990). | PubMed  | ISI | ChemPort |
  24. Vance, J.M. et al. Genomics 9, 623−628 (1991). | PubMed  | ISI | ChemPort |
  25. Epstein, C.J. The Consequences of Chromosome Imbalance Principles, Mechanisms, and Models (Cambridge University Press, Cambridge, 1986).
  26. Tandan, R. et al. Neurology 40, 773−779 (1990). | PubMed  | ISI | ChemPort |
  27. Patel, P.I. et al. Am. J. hum. Genet. 46, 801−809 (1990). | PubMed  | ISI | ChemPort |
  28. Chenevix-Trench, G. Am. J. hum. Genet. 46, 635−636 (1990). | PubMed  | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1992 Nature Publishing Group | Privacy policy